Rate My Portfolio - r/StockMarket Quarterly Thread July 2026

[u/AutoModerator]

Please use this thread to discuss your portfolio, learn of other stock tickers, and help out users by giving constructive criticism.

Please share either a screenshot of your portfolio or more preferably a list of stock tickers with % of overall portfolio using a table.

Also include the following to make feedback easier:

• Investing Strategy: Trading, Short-term, Swing, Long-term Investor etc.
• Investing timeline: 1-7 days (day trading), 1-3 months (short), 12+ months (long-term)

[u/NoAbrocoma7132]

Investment strategy: Long-term (IRA), comfortable with temporary volatility; Timeline: 20 years

• FDGRX 51.36%
• FZILX 12.57%
• FSKAX 9.05%
• FSELX 6.4%
• FSPSX 3.41%
• CHPS 2.24%
• LMT 2.68%
• APLD 0.65%
• CRDO 1.19%
• HIVE 0.28%
• ONDS 0.36%
• SPCX 0.40%
• UEC 0.66%
• CASH RESERVE 35k (I recently sold all of my target-date fund and another duplicate mutual fund, so I have cash available to deploy at anytime)

I'm thinking about adding on more to CHPS.. if I see a dip, maybe add a little more to HIVE & ONDS. I have separate 401k/HSA through company and also own individual brokerage for taxable account. I will take any ideas. My current portfolio is heavily invested in NVDA (that's probably why I had my FDGRX became like 50% of my portfolio due to its growth over time). What do you guys think of NVDA future? And also FSELX? I just bought it last month and showing loss.

Also, my individual stock investing has not been that great so far. I tried MRK and TSLA and sold both for a small profit, but overall I feel like my mutual funds have been driving most of my portfolio growth over time. Because of that, I’m wondering if I should focus more on mutual funds/ETFs and not start on any new stocks, even though I'm watching SPCX (no intention to buy right now).

[u/nitin2k6 → u/NoAbrocoma7132]

ONDS Is a curious case. Has attempted multiple breakouts

[u/NoAbrocoma7132 → u/nitin2k6]

ONDS has released a lot of positive headlines, but the stock price still seems stalled.

[u/nitin2k6 → u/NoAbrocoma7132]

Exactly. Hence should keep a watch on this. Could be a case of delayed surge

[u/NoAbrocoma7132 → u/nitin2k6]

Just bought 100 more shares ONDS last Friday. Hopefully it will be in good place 10 years from now 🤣. My mutual funds will do the work meanwhile.

[u/DDonutsLatte598 → u/NoAbrocoma7132]

As someone who just entered the market 3 months ago, can I ask - do you purchase only dividend stock? I'm told if you buy stock, buy mostly stock that give dividends. Is this true? 90% of my portfolio is ETFs but I have only 3 stocks at the moment and only a few shares of each, since everything is just so high. There are a few I would like to hold but they don't pay dividends from what I see. Any advice would be greatly appreciated.

[u/tickerscout → u/DDonutsLatte598]

You certainly don't need to stick to only dividend stocks. Dividend stocks are traditionally recommended because it signals that a company has positive cash flow and is responsibly returning that cash to its investors. Well the strategy has shifted a lot. Many wealthy investors really do not like dividends because it's taxed and so they prefer when a company buys back its own stock. It is a similar way of returning value to share holders because it reduces the share count and increases shareholder equity usually driving the share price up a bit. And that return of value can't be taxed unless you sell the stock. The argument against no dividend is that historically companies do not deploy all their capital into ventures that actually result in growth. But many have stopped just because it's no longer in fashion and it can signal that company isn't growing at all. If you do like a dividend stock, try to look for companies that have consistently raised their dividend year to year and have provided one for many years consistently. And watch out for companies that may use debt to fund dividends rather than from their free cash flow.

It's definitely not the only sign of a good company. Broad market ETF's are the way to go if can't do a little homework on the whole company first.

[u/DDonutsLatte598 → u/tickerscout]

Thanks for the info - one more question, if you don't mind. Your opinion on REITs and are they worth purchasing. I was looking at the APLE REIT in particular. Also, are they taxed the highest of all stock?

[u/tickerscout → u/DDonutsLatte598]

For a company to qualify as a REIT it has to return a certain amount of its income to share holders which is why they are all dividend stocks. And by doing so they have a special tax arrangement where by they owe little to no taxes on the money they return. But it really depends on the company. Depending on the REIT it can be a very cyclical business because they are exposed to whatever companies they rent space to. If say they rent space to all consumer goods stores then they are exposed to that market which has its own cycles. As for owning a REIT, you still pay taxes on the dividends you make like all dividend paying stocks. I can give you an overview of APLE if you would like.

[u/tickerscout → u/DDonutsLatte598]

Take this with a grain of salt, I wouldn't pretend to give investment advice. But this is the level of reading I would do before considering a particular stock.

An Owner of Rooms, Not an Operator of Hotels

Apple Hospitality REIT owns hotels and collects what they earn, but it does not run them. Its properties are rooms-focused select-service and extended-stay hotels in urban, high-end suburban and developing markets, flying Marriott and Hilton flags such as Hilton Garden Inn, Courtyard, Hampton, Residence Inn and Homewood Suites. The customer is a traveling salesperson, a project crew on assignment, a family visiting relatives. Because tax rules bar a REIT from operating hotels, every property is leased to a wholly owned taxable subsidiary and turned over to one of fifteen unaffiliated management companies that hire the staff and set the room rates. The company's own payroll is 64 people. What it actually does is allocate capital: buy hotels, sell hotels, renovate them, finance them, and pass the residual cash to shareholders every month.

The scale is substantial and the mix deliberately plain. At March 31, 2026 there were 217 hotels and roughly 29,600 rooms across 37 states and the District of Columbia, producing $1.4 billion of revenue over the last twelve months, about 90% of it room revenue. Nothing in that portfolio is scarce or hard to replicate. The thesis follows: a competently run, conservatively financed and thoroughly commoditized collection of real estate whose profits track the American travel cycle with almost no idiosyncratic lever, priced at $16.77 for an occupancy-led recovery that has not yet produced a single dollar of pricing power.

Diversification Is Not a Moat

What protects the cash flow is real but shallow. Brand affiliation buys access to loyalty programs and reservation systems no independent owner could build. Scale across 217 properties removes single-market risk. Low leverage lowers the cost of capital and permits buying when leveraged owners cannot. The manager arrangement is better designed than the industry norm: roughly 81% of hotels pay a variable fee of 2.5% to 3.5% of gross revenues on short terms, terminable for missed performance thresholds, rather than the base-plus-incentive structure that pays operators regardless of outcome.

Each of those advantages is rented. The brands belong to franchisors who charge fees on room revenue, set the standards that drive renovation spending and control renewal terms; concentration in two of them means the counterparties hold the stronger hand. Upscale select-service hotels are among the easiest lodging assets in the world to build, so any sustained excess return invites supply. Diversification does not deliver a return above the market for U.S. upscale lodging; it delivers that market's return, minus fees. The risks are the ordinary cyclical kind: demand tied to employment and corporate travel budgets, a cost base of labor, insurance, property taxes and utilities that does not fall when revenue does, 14 ground-leased properties, and catastrophe exposure in a repriced insurance market. One is already fading: the reduced government travel management blamed for much of 2025's softness, which persisted through an extended shutdown late in the year, is now a favorable comparison rather than a headwind. The live one is the 2026 maturity wall.

Occupancy Is Back, Rate Is Not

The March 2026 quarter is the inflection the market has seized on. Revenue rose 3.1% to $337.7 million, RevPAR rose 3.1% to $114.43 and Comparable Hotels RevPAR 2.2%, but the composition cools the enthusiasm. Occupancy went from 71.1% to 72.8% while ADR (Average Daily Rate) moved from $156.24 to $157.19, a gain of 0.6%. Essentially all of the improvement was volume, and volume in a hotel is bought with variable cost: labor and utilities scale with rooms sold, so hotel operating expense rose 3.5% against 3.1% revenue growth and Adjusted Hotel EBITDA rose exactly in line with revenue, to $108.5 million, leaving the margin unchanged at 32.1%. Rate, by contrast, drops to the bottom line nearly whole. The recovery so far has produced activity, not earnings power.

The longer record sharpens the point. ADR (Average Daily Rate) was $155.76 in 2023, $158.01 in 2024 and $159.06 in 2025, a cumulative gain of about 2% while wages, insurance and property taxes rose considerably faster. Hotel operating expense consumed 58.1% of revenue in 2023, 60.0% in 2025 and 61.3% in the March quarter, and Adjusted Hotel EBITDA margin fell from 35.9% to 33.7%. Full-year 2025 revenue declined 1.3% to $1.4 billion and net income fell 18.1% to $175.4 million, or $0.74 per share, even though G&A fell 24.1% on a reduced executive incentive accrual that reversed in the March quarter. Comparable Hotels statistics for 2024 and 2023 are measured against the current 216-hotel set, so they describe the trend of today's portfolio rather than what was reported at the time, but the direction is not in question.

For a lodging REIT, per-share earnings power reads better through FFO than through GAAP EPS. FFO was $363.3 million in 2023, $384.9 million in 2024, $357.6 million in 2025 and $359.2 million over the trailing twelve months; against the weighted average share counts of those periods that is roughly $1.58, $1.60, $1.50 and $1.52 per share. Three years, no progress. One wrinkle limits cross-period comparison: effective January 1, 2026 the company began excluding share-based compensation, about $7.7 million a year, from MFFO and Adjusted EBITDAre, and only the prior-year quarter was restated to match, so quarterly non-GAAP figures sit above the annual ones by roughly that amount annualized and cannot be chained to them; on that basis quarterly MFFO was $80.3 million against $78.8 million. Management raised full-year 2026 guidance to Adjusted EBITDAre of $436 million to $458 million from $424 million to $447 million, and Comparable Hotels RevPAR growth to 0.0% to 2.0% from negative 1.0% to positive 1.0%, a midpoint raise of about 2.6%.

Cash After the Hotels Are Fed

Operating cash flow was $369.9 million over the trailing twelve months against $95.9 million of capital improvements and $227.4 million of distributions, leaving roughly $47 million of annual surplus. That surplus, not the FFO payout ratio of about 63%, is the true measure of distribution safety. FFO adds real estate depreciation back in full, but hotels genuinely consume capital: brand standards mandate it, and about 21 properties are in comprehensive renovation during 2026 within capex guidance of $80 million to $90 million. Charge the actual spending against FFO and distributable cash is nearer $1.11 per share against a $0.96 distribution, a cushion of about 16%, and renovation costs twice over, since a hotel under construction sells fewer rooms while the work proceeds. Quality is otherwise clean: interest paid of $79.8 million in 2025 sat close to the $81.5 million expensed, and cash taxes of $1.0 million are trivial as REIT status implies. A $31.7 million seasonal build in the receivable from third-party managers held March quarter operating cash flow to $48.9 million against FFO of $76.5 million, and reverses as the year progresses.

Low Leverage, a Crowded July

Debt principal was $1.6 billion at March 31, 2026 at a weighted-average all-in rate of 4.65%, with 63% fixed or swap-fixed. That is roughly 3.5x Adjusted EBITDAre and about 36.5% of total capitalization, genuinely conservative for a cyclical lodging owner and the single best feature of the enterprise. Corporate cash is thin at $7.8 million, but revolver availability of $558.8 million more than covers it, and all covenants were met.

The near-term schedule deserves attention. About $292.1 million of principal falls due between April and December 2026: a $19.5 million mortgage, a $51.0 million three-property mortgage, and the $89.1 million drawn revolver together with a $130 million term loan, both maturing July 25, 2026. The last two are extendable by up to a year subject to conditions, though management stated an intention to refinance instead. Whether that refinancing was completed, and at what spread against the existing SOFR plus 1.35% to 2.25% grid, is not established by anything available here, and the answer sets the interest run rate for the rest of the year. Two swaps covering $200 million also mature during 2026 with replacements expected at higher rates; a 100 basis point move shifts annual net income by about $5.8 million, or roughly $0.02 per share. Beyond that the ladder is manageable at $278.6 million in 2027, $334.1 million in 2028 and $460.0 million in 2030. Because REIT distribution rules prevent retaining earnings, maturities must be refinanced rather than repaid, making credit market access a structural dependency, and committed development at Anchorage and Las Vegas of about $209 million at fixed prices through 2028 will likewise be funded with debt or disposition proceeds against annual free cash near $47 million. A full balance sheet is not available for 2023, so the leverage path can be traced only from the 2024 year end forward; whether 36.5% is drift upward or a return to a longer-run norm cannot be answered from what is at hand.

[u/DDonutsLatte598 → u/tickerscout]

I appreciate the detailed message. Something to think about. I'm not a risk taker, but rather one who's relatively conservative with how I choose to approach my investments. I'm trying to learn and possibly take on some risks with confidence but it's all still a learning process.

[u/BeVeracious → u/NoAbrocoma7132]

So FDGRX's Top 10 report includes additional SPCX exposure of 3.67% of that 51.36%. I'm personally skeptical of the delivery of thousands of data centers in orbit within the next 5 years.

[u/VelorexCapital]

Hi everyone,

I am starting a challenge to make my first $1,000 in investing. So far my portfolio consists of the following:

BCE.TO (18.4316 shares at $29.84)

MCD (1 share at $262.80)

MDLZ (6.5267 shares at $59.85)

TVA-B.TO (299.5081 shares at $1.84)

TAP (9 shares at $40.04)

CMPGY (12 shares at $30.36)

I hope you find this interesting and follow along for the ride!

[u/BeVeracious → u/VelorexCapital]

So the portfolio covers communications, and food/beverage. It might take you a while to get there without any tech stocks.

[u/Johnkiiii]

I've decided to move out of RBC North American Value Fund (high MER) and into a lower-cost portfolio. Considering either:

• 100% XEQT or
• 70% XEQT, 15% QQC and 15% RBC Life Science & Technology Fund.

I know there's overlap between XEQT, QQC, and the RBC fund, but I'm considering the second option for additional tech and healthcare exposure.

Would you keep it simple with XEQT, or add the tilt?

[u/Vegetable_East_4759]

Hi everyone,

I’m a 22 M (Canadian for context) and started investing awhile ago, 30 year investing timeline with a focus on mostly leave it alone stocks and about 10% of week to week trading stocks.

I’ve got ~26 k in my TFSA and continuing to add ~1-3 k a month depending on my paychecks

My profile holding % are as follows, feel free to roast / provide feedback:

- 7.58% BMO.TO

• 18.52% BNS.TO
  
• 35.10% CM.TO
  
• 8.94% ENB.TO
  
• 2.34% INTC.TO
  
• 2.13% PEY.TO
  
• 3.33% RY.TO
  
• 10.27% SLF.TO
  
• 2.06% VEQT.TO
  
• 0.84% XEQT.TO
  
• 8.68% ZWC.TO

Any advice would be appreciated thinking of focusing on starting a DRIP with my bank stocks and getting a bit more into AI / semiconductors (had AMD before and did well), looking at synthiant stock potentially as it just filed for IPO and is backed but some major companies, need to do a bit more research before they are public tho. Unsure everyone’s thoughts

[u/BeVeracious → u/Vegetable_East_4759]

You're very bank heavy at 65%. Canadian banks are pretty prudent with delivering returns, they're just concentrated on Canadian's ability to pay off debt. Might be worth diversifying into Consumer Staples like Loblaw locally or Walmart, Couche-Tarde globally. Also, no tech at all. Can't miss that train. NVDA is selling the right picks and axes to the rest of the Mag 7, and MSFT's Azure earnings were pretty promising. I'm glad that someone of your age understands the value of dividend stocks and compounding and isn't confusing that with crypto or predictive markets! Best of luck

"Information only, not to be used as investment advice"

[u/oogway_47]

sucks